Skip to search formSkip to main contentSkip to account menu

SR 21502

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Efficacy of Dopamine D3 Receptor Antagonist SR 21502 in Reducing Opioid Tolerance and Dependence
Dopamine (DA) D3 antagonists modulate the addictive and rewarding properties of both stimulant and opioid drugs by deactivating… 
2014
2014
The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats
2013
2013
The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats
There is a focus on developing D3 receptor antagonists as cocaine addiction treatments. We investigated the effects of a novel… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)